nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—urine—bipolar disorder	0.266	0.416	CbGeAlD
Ximelagatran—F2—blood plasma—bipolar disorder	0.139	0.217	CbGeAlD
Ximelagatran—CYP2C9—urine—bipolar disorder	0.106	0.166	CbGeAlD
Ximelagatran—CYP2C9—blood plasma—bipolar disorder	0.0553	0.0866	CbGeAlD
Ximelagatran—F2—nervous system—bipolar disorder	0.0412	0.0646	CbGeAlD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—ADRBK2—bipolar disorder	0.0376	0.104	CbGpPWpGaD
Ximelagatran—F2—brain—bipolar disorder	0.0315	0.0494	CbGeAlD
Ximelagatran—F2—Complement and Coagulation Cascades—SERPINA1—bipolar disorder	0.012	0.0331	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—NR3C1—bipolar disorder	0.00825	0.0228	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—DGKH—bipolar disorder	0.00784	0.0217	CbGpPWpGaD
Ximelagatran—F2—IL1 and megakaryotyces in obesity—IL1B—bipolar disorder	0.00759	0.021	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00701	0.0194	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—MTHFR—bipolar disorder	0.007	0.0194	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—DGKH—bipolar disorder	0.00686	0.019	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—INS—bipolar disorder	0.00626	0.0173	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—MTHFR—bipolar disorder	0.00569	0.0157	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—INS—bipolar disorder	0.00557	0.0154	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00544	0.015	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.0054	0.0149	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—TACR1—bipolar disorder	0.00505	0.014	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—TACR1—bipolar disorder	0.00499	0.0138	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00486	0.0134	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TRPC3—bipolar disorder	0.00476	0.0132	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00475	0.0131	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—INS—bipolar disorder	0.00453	0.0125	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—MTHFR—bipolar disorder	0.00452	0.0125	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00452	0.0125	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.00416	0.0115	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—IL1B—bipolar disorder	0.00415	0.0115	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—TAC1—bipolar disorder	0.00412	0.0114	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—TAC1—bipolar disorder	0.00407	0.0113	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00404	0.0112	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00368	0.0102	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD5—bipolar disorder	0.00362	0.01	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00361	0.00999	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—INS—bipolar disorder	0.0036	0.00995	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—DGKH—bipolar disorder	0.00354	0.00978	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—IL1B—bipolar disorder	0.00338	0.00935	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00335	0.00926	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00335	0.00926	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00292	0.00807	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00277	0.00766	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00273	0.00755	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL1B—bipolar disorder	0.00268	0.00742	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00268	0.0074	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00268	0.0074	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—ADM—bipolar disorder	0.00262	0.00723	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00259	0.00717	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—TACR1—bipolar disorder	0.00255	0.00705	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—TSHB—bipolar disorder	0.00255	0.00705	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00252	0.00696	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00248	0.00685	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TRPC3—bipolar disorder	0.00245	0.00678	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00234	0.00648	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DGKH—bipolar disorder	0.00224	0.00618	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00222	0.00613	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINA1—bipolar disorder	0.00214	0.00593	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR1A—bipolar disorder	0.00211	0.00583	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—TAC1—bipolar disorder	0.00208	0.00575	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD5—bipolar disorder	0.00204	0.00565	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD1—bipolar disorder	0.00204	0.00564	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2C—bipolar disorder	0.00204	0.00564	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DGKH—bipolar disorder	0.00203	0.00561	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—RGS4—bipolar disorder	0.002	0.00554	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00199	0.0055	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD3—bipolar disorder	0.00197	0.00546	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—POMC—bipolar disorder	0.00195	0.00541	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD4—bipolar disorder	0.00192	0.0053	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD5—bipolar disorder	0.00186	0.00513	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—GATA3—bipolar disorder	0.00182	0.00504	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RGS4—bipolar disorder	0.00182	0.00504	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TSHB—bipolar disorder	0.00179	0.00496	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—DRD2—bipolar disorder	0.00178	0.00494	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00164	0.00454	CbGpPWpGaD
Ximelagatran—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.0016	0.00441	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—TRPC3—bipolar disorder	0.00155	0.00429	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADM—bipolar disorder	0.00148	0.00409	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—TSHB—bipolar disorder	0.00144	0.00398	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—TACR1—bipolar disorder	0.00144	0.00398	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PDE4B—bipolar disorder	0.00144	0.00398	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TRPC3—bipolar disorder	0.00141	0.00389	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—GSK3A—bipolar disorder	0.00138	0.00382	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADM—bipolar disorder	0.00134	0.00371	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00131	0.00363	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PDE4B—bipolar disorder	0.00131	0.00362	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TSHB—bipolar disorder	0.00131	0.00362	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TACR1—bipolar disorder	0.00131	0.00362	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKR1C4—bipolar disorder	0.0013	0.0036	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00129	0.00358	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—TCF7L2—bipolar disorder	0.00126	0.0035	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2A—bipolar disorder	0.00125	0.00346	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DGKH—bipolar disorder	0.0012	0.00332	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR1A—bipolar disorder	0.00119	0.0033	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—TAC1—bipolar disorder	0.00117	0.00325	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD1—bipolar disorder	0.00115	0.00318	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2C—bipolar disorder	0.00115	0.00318	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00114	0.00314	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD3—bipolar disorder	0.00112	0.00308	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD5—bipolar disorder	0.0011	0.00303	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR1A—bipolar disorder	0.00108	0.00299	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD4—bipolar disorder	0.00108	0.00299	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RGS4—bipolar disorder	0.00108	0.00297	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—TAC1—bipolar disorder	0.00107	0.00295	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—COMT—bipolar disorder	0.00106	0.00294	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—MAOA—bipolar disorder	0.00106	0.00292	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	0.00105	0.0029	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD1—bipolar disorder	0.00105	0.00289	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2C—bipolar disorder	0.00105	0.00289	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00102	0.00282	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADCY2—bipolar disorder	0.00102	0.00282	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD3—bipolar disorder	0.00101	0.0028	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—DRD2—bipolar disorder	0.00101	0.00279	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—bipolar disorder	0.000998	0.00276	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD4—bipolar disorder	0.000983	0.00272	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADCY2—bipolar disorder	0.000925	0.00256	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—DRD2—bipolar disorder	0.000916	0.00253	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—IMPA2—bipolar disorder	0.00091	0.00252	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TRPC3—bipolar disorder	0.000831	0.0023	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADM—bipolar disorder	0.000793	0.00219	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSHB—bipolar disorder	0.000773	0.00214	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDE4B—bipolar disorder	0.000773	0.00214	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TACR1—bipolar disorder	0.000773	0.00214	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000706	0.00195	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—bipolar disorder	0.000702	0.00194	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—INS—bipolar disorder	0.000698	0.00193	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000692	0.00191	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.000687	0.0019	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2A—bipolar disorder	0.000641	0.00177	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR1A—bipolar disorder	0.00064	0.00177	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TAC1—bipolar disorder	0.00063	0.00174	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2C—bipolar disorder	0.000618	0.00171	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD1—bipolar disorder	0.000618	0.00171	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000615	0.0017	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK2—bipolar disorder	0.000601	0.00166	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000601	0.00166	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD3—bipolar disorder	0.000598	0.00165	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GSK3A—bipolar disorder	0.000596	0.00165	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD4—bipolar disorder	0.000581	0.00161	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—bipolar disorder	0.000564	0.00156	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADCY2—bipolar disorder	0.000547	0.00151	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TCF7L2—bipolar disorder	0.000545	0.00151	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DRD2—bipolar disorder	0.000541	0.0015	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000523	0.00145	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—bipolar disorder	0.000512	0.00142	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000506	0.0014	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK1—bipolar disorder	0.00049	0.00135	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—S100B—bipolar disorder	0.000476	0.00132	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000455	0.00126	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000435	0.0012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.000426	0.00118	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRG1—bipolar disorder	0.00042	0.00116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2A—bipolar disorder	0.000379	0.00105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CLOCK—bipolar disorder	0.000308	0.000852	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GSK3B—bipolar disorder	0.000305	0.000844	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—bipolar disorder	0.000303	0.000837	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—INS—bipolar disorder	0.000301	0.000832	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TSHB—bipolar disorder	0.0003	0.00083	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TPH2—bipolar disorder	0.0003	0.00083	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNB2—bipolar disorder	0.0003	0.00083	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DPYD—bipolar disorder	0.000295	0.000817	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNA1C—bipolar disorder	0.000275	0.000759	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	0.000268	0.00074	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000264	0.00073	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SNAP25—bipolar disorder	0.00024	0.000664	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADCY2—bipolar disorder	0.000212	0.000587	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COMT—bipolar disorder	0.000182	0.000503	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MAOA—bipolar disorder	0.000181	0.000499	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—bipolar disorder	0.000147	0.000406	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—bipolar disorder	0.000118	0.000325	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—INS—bipolar disorder	0.000117	0.000323	CbGpPWpGaD
